KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Tax Provisions: 2018-2024

Historic Tax Provisions for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $3.3 million.

  • Castle Biosciences' Tax Provisions fell 98.09% to $115,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 232.59%. This contributed to the annual value of $3.3 million for FY2024, which is 3186.14% up from last year.
  • Latest data reveals that Castle Biosciences reported Tax Provisions of $3.3 million as of FY2024, which was up 3,186.14% from $101,000 recorded in FY2023.
  • Castle Biosciences' 5-year Tax Provisions high stood at $3.3 million for FY2024, and its period low was -$8.7 million during FY2021.
  • For the 3-year period, Castle Biosciences' Tax Provisions averaged around $551,333, with its median value being $101,000 (2023).
  • Its Tax Provisions has fluctuated over the past 5 years, first crashed by 10,480.95% in 2021, then spiked by 3,186.14% in 2024.
  • Over the past 5 years, Castle Biosciences' Tax Provisions (Yearly) stood at $84,000 in 2020, then tumbled by 10,480.95% to -$8.7 million in 2021, then skyrocketed by 79.75% to -$1.8 million in 2022, then soared by 105.72% to $101,000 in 2023, then soared by 3,186.14% to $3.3 million in 2024.